Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Gold.com Inc GOLD

Metals & Mining Gold Industrial Metals & Minerals
A-Mark Precious Metals, Inc., together with its subsidiaries, operates as a precious metals company. It operates through three segments: Wholesale Sales & Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Sales & Ancillary Services segment sells gold, silver, platinum, and palladium in the form of bars, plates, powders, wafers, grains, ingots, and coins. This segment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:GOLD)

A-Mark Precious Metals to Become Gold.com and Transfer to the New York Stock Exchange

GlobeNewswire November 6, 2025

A-Mark Precious Metals Reports Fiscal First Quarter 2026 Results and Announces Definitive Agreement to Acquire Monex Precious Metals, a Leading DTC Brand

GlobeNewswire November 6, 2025

A-Mark Precious Metals Announces Quarterly Cash Dividend

GlobeNewswire October 29, 2025

A-Mark Precious Metals Sets Fiscal First Quarter Earnings Call for Thursday, November 6th at 4:30 p.m. ET

GlobeNewswire October 20, 2025

A-Mark Precious Metals' Stack's Bowers Galleries Subsidiary Selected by the United States Mint to Auction Seven Sacagawea Gold Dollars that Orbited Earth Aboard the Space Shuttle Columbia in July 1999

GlobeNewswire September 16, 2025

A-Mark Precious Metals Reports Fiscal Fourth Quarter and Full Year 2025 Results

GlobeNewswire September 9, 2025

A-Mark Precious Metals Sets Fiscal Fourth Quarter and Full Year 2025 Earnings Call for Tuesday, September 9th at 4:30 p.m. ET

GlobeNewswire August 25, 2025

A-Mark Precious Metals Announces Quarterly Cash Dividend

GlobeNewswire July 7, 2025

A-MARK INVESTOR NOTIFICATION: Kaskela Law LLC Announces Investigation into Fairness of A-Mark Precious Metals, Inc. (NASDAQ: AMRK) Merger and Encourages Investors to Contact the Firm

Business Wire May 21, 2025
View More News ››

Opinion & Analysis (NYSE:GOLD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:GOLD)

A-Mark Precious Metals: A Diversified Powerhouse in the Glob

Looks like a solid play in the precious metals space. AMRK's diversified model is impressive - $9.7B revenue, multiple segments...
MikeTester - January 24, 2025

Is this a `Kuppy Spike'?

Or is it a durable trading range? Stockhouse's chart show a ten bagger from the pandemic-panic lows of $3.33 on March 20, 2020 to the...
rogueecon - April 9, 2024
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »